Hua Mu

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China.

Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.

Part of Procter & Gamble Co., Procter & Gamble AG engages in marketing of consumer goods. The Swiss company was founded by Ofir Bar Levav.

Overland Pharmaceuticals is a Chinese biopharmaceutical company that is focused on developing and commercializing innovative medicines in underserved areas around the world. The private company is based in an undisclosed location and is leveraging its resources and network to establish a portfolio of differentiated therapeutic candidates in carefully selected therapeutic areas. Overland Pharmaceuticals is building a fully integrated biopharma company through formative partnerships and is committed to bringing innovative medicines to underserved patients. The company was founded by Hua Mu and Ed Zhang, with Ed Zhang serving as CEO since incorporation.